Search Results - "Markati, Theodora"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    The use of digital outcome measures in clinical trials in rare neurological diseases: a systematic literature review by Poleur, Margaux, Markati, Theodora, Servais, Laurent

    Published in Orphanet journal of rare diseases (02-08-2023)
    “…Developing drugs for rare diseases is challenging, and the precision and objectivity of outcome measures is critical to this process. In recent years, a number…”
    Get full text
    Journal Article Web Resource
  2. 2

    Lessons Learned from Discontinued Clinical Developments in Duchenne Muscular Dystrophy by Markati, Theodora, De Waele, Liesbeth, Schara-Schmidt, Urlike, Servais, Laurent

    Published in Frontiers in pharmacology (01-11-2021)
    “…Duchenne muscular dystrophy (DMD) is an X-linked condition caused by a deficiency of functional dystrophin protein. Patients experience progressive muscle…”
    Get full text
    Journal Article Web Resource
  3. 3
  4. 4

    Emerging therapies for Duchenne muscular dystrophy by Markati, Theodora, Oskoui, Maryam, Farrar, Michelle A, Duong, Tina, Goemans, Nathalie, Servais, Laurent

    Published in Lancet neurology (01-09-2022)
    “…Duchenne muscular dystrophy is an X-linked disease caused by the absence of functional dystrophin in the muscle cells. Major advances have led to the…”
    Get full text
    Journal Article Web Resource
  5. 5

    A systematic review of adeno-associated virus gene therapies in neurology: the need for consistent safety monitoring of a promising treatment by Horton, Rebecca H, Saade, Dimah, Markati, Theodora, Harriss, Elinor, Bönnemann, Carsten G, Muntoni, Francesco, Servais, Laurent

    “…Adeno-associated virus (AAV) gene therapies are generating much excitement in the rare disease field, particularly for previously untreatable neurological…”
    Get full text
    Journal Article Web Resource
  6. 6

    Early clinical and pre-clinical therapy development in Nemaline myopathy by Fisher, Gemma, Mackels, Laurane, Markati, Theodora, Sarkozy, Anna, Ochala, Julien, Jungbluth, Heinz, Ramdas, Sithara, Servais, Laurent

    Published in Expert opinion on therapeutic targets (03-10-2022)
    “…Nemaline myopathies (NM) represent a group of clinically and genetically heterogeneous congenital muscle disorders with the common denominator of nemaline rods…”
    Get more information
    Journal Article
  7. 7